Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

China flag China · Delayed Price · Currency is CNY
36.21
+3.29 (9.99%)
Apr 30, 2025, 3:04 PM CST
Market Cap 57.60B
Revenue (ttm) 19.98B
Net Income (ttm) 2.49B
Shares Out 1.59B
EPS (ttm) 1.57
PE Ratio 23.09
Forward PE 16.17
Dividend 1.01 (2.78%)
Ex-Dividend Date Oct 23, 2024
Volume 41,984,799
Average Volume 23,356,269
Open 35.43
Previous Close 32.92
Day's Range 31.81 - 36.21
52-Week Range 25.72 - 38.08
Beta -0.07
RSI 59.84
Earnings Date Apr 24, 2025

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sic... [Read more]

Sector Healthcare
Founded 1996
Employees 21,864
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002422
Full Company Profile

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.

Financial Statements

News

There is no news available yet.